Core E: Cell sorting, CyTOF and RNA-Seq
核心 E:细胞分选、CyTOF 和 RNA-Seq
基本信息
- 批准号:10188604
- 负责人:
- 金额:$ 54.45万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-08-01 至 2022-05-31
- 项目状态:已结题
- 来源:
- 关键词:AliquotAllelesAntibodiesAntigen-Presenting CellsAntigensArterial Fatty StreakArteriesAtherosclerosisB-LymphocytesBLR1 geneBioinformaticsBiologicalBone MarrowCD4 Positive T LymphocytesCXCR4 geneCaliforniaCell CommunicationCell SeparationCell surfaceCellsCytometryDNADataData AnalysesDimensionsEnsureFlow CytometryFreezingGenesGenomeGenomicsGreater sac of peritoneumHLA AntigensHandHarvestHumanImmuneIn VitroIndividualInstitutesLanthanoid Series ElementsLeukocytesLibrariesLiquid substanceMapsMemoryMethodsModernizationMonoclonal AntibodiesMusNational Heart, Lung, and Blood InstituteNitrogenNucleotidesPathway AnalysisPatientsPerformancePeripheral Blood Mononuclear CellPeritonealPhenotypePlasmaPopulationPreparationPrincipal Component AnalysisProteinsQuality ControlRNARare Earth MetalsRunningSamplingShippingShipsSpleenT-LymphocyteTechnologyTimeTissuesTrans-Omics for Precision MedicineTubeUniversitiesVirginiaantibody conjugatebasecell typedata qualitydesigndifferential expressiondimensional analysisexperienceexperimental studygenome-widehigh dimensionalityhuman RNA sequencinghuman datahuman leukocyte antigen testingin vivoinstrumentmacrophagemass spectrometermonocytenovelpreservationterminally differentiated effector memory (TEM) T cellstooltranscription factortranscriptometranscriptome sequencingtrizolvapor
项目摘要
Core E description
Core E has four functions, serving all 4 projects. First, human and mouse T cells, B cells and monocytes will be
sorted from peripheral blood mononuclear cells (PBMCs) and sorted into trizol, RNA extracted, quality controls
(bioanalyzer, Agilent TapeStation) performed, libraries prepared and RNA-Seq done to obtain ~50-70 million
Illumina reads per sample. Preliminary data show excellent sequencing depth and data quality even in long-
term frozen PBMCs. Mouse and human samples are focused on monocyte subsets for project 1, treated
human and sorted mouse macrophages for project 2, B1 cells from peritoneal cavity, spleen and bone marrow
in wild-type, Cxcr4-/- and Cxcr5-/- mice for project 3, and dextramerhigh, dextramerlow, dextramernegative effector
memory (TEM) cells and naïve CD4 T cells for project 4. Second, 36 to 42-parameter mass cytometry (CyTOF)
followed by high-dimensional analysis (SPADE, viSNE) will be used for unsupervised clustering. We have
already acquired or conjugated, titrated and validated more than 100 monoclonal antibodies, developed one
human panel that will serve all projects and four human panels that serve each project individually. We will use
about 1 million cells from each tube for this, and the remaining about 7 million cells will be used for RNA-Seq.
We also will run CyTOF on mouse. CyTOF identifies the known cell types and likely will suggest new, unknown
cell types (new subsets of monocytes, B cells, T cells). Third, sorted T cells and antigen presenting cells
(APCs) will be distributed to project 4 and sorted monocytes to project 1 for functional experiments in vivo and
in vitro as detailed in the projects. Finally, core E will also provide basic bioinformatics support. This includes
post-sequencing quality controls for RNA-Seq, mapping reads, differential expression (DE), heat maps, Venn
diagrams and principal component analysis (PCA).
Core E描述
核心E有四个功能,服务于所有四个项目。首先,人类和小鼠的T细胞、B细胞和单核细胞将被
从外周血单核细胞(PBMC)中分选并分选到Trizol中,提取RNA,质量控制
(生物分析仪,Agilent TapeStation),制备文库并进行RNA-Seq,以获得约5000 - 7000万
Illumina读取每个样品。初步数据显示,即使在长时间的测序中,
足月冷冻PBMC。小鼠和人类样本的重点是项目1的单核细胞亚群,经过处理
人和分选小鼠巨噬细胞从腹腔、脾和骨髓中投射2、B1细胞
在野生型、Cxcr 4-/-和Cxcr 5-/-小鼠中,对于项目3,和右旋糖酐高、右旋糖酐低、右旋糖酐阴性效应子
记忆(TEM)细胞和幼稚CD 4 T细胞用于项目4。第二,36至42参数质谱细胞仪(CyTOF)
随后的高维分析(SPADE,viSNE)将用于无监督聚类。我们有
已经获得或结合,滴定和验证了100多个单克隆抗体,开发了一个
一个为所有项目服务的人工小组和四个分别为每个项目服务的人工小组。我们将使用
每个试管中约有100万个细胞,其余约700万个细胞将用于RNA-Seq。
我们还将在小鼠上运行CyTOF。CyTOF识别了已知的细胞类型,并可能提示新的未知细胞类型。
细胞类型(单核细胞、B细胞、T细胞的新亚群)。第三,分选的T细胞和抗原呈递细胞
(APC)将被分配到项目4,并将分选的单核细胞分配到项目1,用于体内功能实验,
如项目中详细说明的那样。最后,核心E还将提供基本的生物信息学支持。这包括
RNA-Seq测序后质量控制、作图读数、差异表达(DE)、热图、Venn
图和主成分分析(PCA)。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Klaus F. Ley其他文献
Binding of function‐blocking mAbs to mouse and human P‐selectin glycoprotein ligand‐1 peptides with and without tyrosine sulfation
功能阻断单克隆抗体与小鼠和人 P-选择素糖蛋白配体 1 肽(有或没有酪氨酸硫酸化)的结合
- DOI:
- 发表时间:
2002 - 期刊:
- 影响因子:5.5
- 作者:
Aravinda Thatte;S. Ficarro;K. Snapp;M. Wild;D. Vestweber;D. Hunt;Klaus F. Ley - 通讯作者:
Klaus F. Ley
Serum levels of soluble intercellular adhesion molecule-1 (sICAM-1) correlate with severity of ileitis in experimental Crohn's disease: A novel marker of small intestinal inflammation
- DOI:
10.1016/s0016-5085(00)85325-1 - 发表时间:
2000-04-01 - 期刊:
- 影响因子:
- 作者:
Jesus Rivera-Nieves;R. Cartland Burns;Christopher A. Moskaluk;Theresa T. Pizarro;Klaus F. Ley;Fabio Cominelli - 通讯作者:
Fabio Cominelli
α<sub>4</sub>β<sub>1</sub>integrin (VLA-4) blockade reduces neointimal growth after carotid air desiccation injury in the ApoE (−/−) mouse
- DOI:
10.1016/s0735-1097(02)80085-7 - 发表时间:
2002-03-06 - 期刊:
- 影响因子:
- 作者:
Kurt G. Barringhaus;J.William Phillips;John M. Sanders;Ann C. Czamik;Klaus F. Ley;Ian J. Sarembock - 通讯作者:
Ian J. Sarembock
Klaus F. Ley的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Klaus F. Ley', 18)}}的其他基金
Mechanism of kindlin-3-dependent integrin activation
kindlin-3依赖性整合素激活机制
- 批准号:
10676897 - 财政年份:2020
- 资助金额:
$ 54.45万 - 项目类别:
Mechanism of kindlin-3-dependent integrin activation
kindlin-3依赖性整合素激活机制
- 批准号:
10229369 - 财政年份:2020
- 资助金额:
$ 54.45万 - 项目类别:
Vascular macrophages and T cells in atherosclerosis
动脉粥样硬化中的血管巨噬细胞和 T 细胞
- 批准号:
10369710 - 财政年份:2019
- 资助金额:
$ 54.45万 - 项目类别:
Vascular macrophages and T cells in atherosclerosis
动脉粥样硬化中的血管巨噬细胞和 T 细胞
- 批准号:
10112954 - 财政年份:2019
- 资助金额:
$ 54.45万 - 项目类别:
Vascular macrophages and T cells in atherosclerosis
动脉粥样硬化中的血管巨噬细胞和 T 细胞
- 批准号:
9895858 - 财政年份:2019
- 资助金额:
$ 54.45万 - 项目类别:
Vascular macrophages and T cells in atherosclerosis
动脉粥样硬化中的血管巨噬细胞和 T 细胞
- 批准号:
10623034 - 财政年份:2019
- 资助金额:
$ 54.45万 - 项目类别:
Vascular macrophages and T cells in atherosclerosis
动脉粥样硬化中的血管巨噬细胞和 T 细胞
- 批准号:
10565907 - 财政年份:2019
- 资助金额:
$ 54.45万 - 项目类别:
Core B: Single Cell Protein and RNA Sequencing Core
核心 B:单细胞蛋白质和 RNA 测序核心
- 批准号:
10334092 - 财政年份:2017
- 资助金额:
$ 54.45万 - 项目类别:
ApoB-specific CD4 T cells in mouse and human atherosclerosis
小鼠和人类动脉粥样硬化中的 ApoB 特异性 CD4 T 细胞
- 批准号:
10188608 - 财政年份:2017
- 资助金额:
$ 54.45万 - 项目类别:
相似海外基金
Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
- 批准号:
502556 - 财政年份:2024
- 资助金额:
$ 54.45万 - 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
- 批准号:
10659303 - 财政年份:2023
- 资助金额:
$ 54.45万 - 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
- 批准号:
10674405 - 财政年份:2023
- 资助金额:
$ 54.45万 - 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
- 批准号:
10758772 - 财政年份:2023
- 资助金额:
$ 54.45万 - 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
- 批准号:
10676499 - 财政年份:2023
- 资助金额:
$ 54.45万 - 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
- 批准号:
2748611 - 财政年份:2022
- 资助金额:
$ 54.45万 - 项目类别:
Studentship
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
- 批准号:
22K05630 - 财政年份:2022
- 资助金额:
$ 54.45万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
- 批准号:
10532032 - 财政年份:2022
- 资助金额:
$ 54.45万 - 项目类别:
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
- 批准号:
10525070 - 财政年份:2022
- 资助金额:
$ 54.45万 - 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
- 批准号:
10689017 - 财政年份:2022
- 资助金额:
$ 54.45万 - 项目类别: